Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats

References

• Ali MK, Siegel KR, Chandrasekar E, Tandon N, Montoya PA, Mbanya J-C, Chan J, Zhang P, Narayan KM. 2017. Chapter 12- Diabetes: an update on the pandemic and potential solutions. In: Prabhakaran D, Anand S, Gaziano T, Mbanya J, Wu Y, and Nugent R, editors. Disease control priorities (Volume 5): Cardiovascular, respiratory, and related disorders. 3rd ed. Washington, DC: International Bank for Reconstruction and Development/World Bank. https://www.ncbi.nlm.nih.gov/books/NBK525150/.
   Google Scholar
• Arroyo P, Ho BS, Sau L, Kelle ST, Thackray VG. 2019. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome. PloS One. 14:e0223274. doi:10.1371/journal.pone.0223274
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Eisenbarth GS, Michels AW. 2014. Type 1 diabetes. Lancet. 383:69–82. doi:10.1016/S0140-6736(13)60591-7
   PubMed Web of Science ®Google Scholar
• Cho YH, Craig ME, Donaghue KC. 2014. Puberty as an accelerator for diabetes complications. Ped Diabetes. 15:18–26. doi:10.1111/pedi.12112
   PubMed Web of Science ®Google Scholar
• Chowdhury S. 2015. Puberty and type 1 diabetes. Ind J Endocrinol Metab. 19:S51–S54. doi:10.4103/2230-8210.155402
   PubMedGoogle Scholar
• Coppolino G, Leporini C, Rivoli L, Ursini F, di Paola ED, Cernaro V, Arturi F, Bolignano D, Russo E, De Sarro G. 2018. Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials. Pharmacol Res. 129:274–294. doi:10.1016/j.phrs.2017.12.001
   PubMed Web of Science ®Google Scholar
• Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, Bell R, Badaru A, Talton JW, Crume T. 2014. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. J Am Med Assoc. 311:1778–1786. doi:10.1001/jama.2014.3201
   PubMed Web of Science ®Google Scholar
• Dabelea D, Stafford JM, Mayer-Davis EJ, D’Agostino R, Dolan L, Imperatore G, Linder B, Lawrence JM, Marcovina SM, Mottl AK. 2017. Association of type 1 diabetes vs. type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. J Am Med Assoc. 317:825–835. doi:10.1001/jama.2017.0686
   PubMed Web of Science ®Google Scholar
• Dehdashtian E, Mehrzadi S, Yousefi B, Hosseinzadeh A, Reiter RJ, Safa M, Ghaznavi H, Naseripour M. 2018. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Life Sci. 193:20–33. doi:10.1016/j.lfs.2017.12.001
   PubMed Web of Science ®Google Scholar
• Dietrich N, Kolibabka M, Busch S, Bugert P, Kaiser U, Lin J, Fleming T, Morcos M, Klein T, Schlotterer A. 2016. The DPP4 inhibitor linagliptin protects from experimental diabetic retinopathy. PloS One. 11:e0167853. doi:10.1371/journal.pone.0167853
   PubMed Web of Science ®Google Scholar
• Dresler M, Sandberg A, Bublitz C, Ohla K, Trenado C, Mroczko-Wasowicz A, Kühn S, Repantis D. 2018. Hacking the brain: dimensions of cognitive enhancement. ACS Chem Neurosci. 10:1137–1148. doi:10.1021/acschemneuro.8b00571
   Web of Science ®Google Scholar
• Düzova H, Nazıroğlu M, Çiğ B, Gürbüz P, Akatlı AN. 2021. Noopept attenuates diabetes-mediated neuropathic pain and oxidative hippocampal neurotoxicity via inhibition of trpv1 channel in rats. Mol Neurobiol. 58:5031–5051. doi:10.1007/s12035-021-02478-8
   PubMed Web of Science ®Google Scholar
• Elks CE, Ong KK, Scott RA, Van Der Schouw YT, Brand JS, Wark PA, Amiano P, Balkau B, Barricarte A, Boeing H. 2013. Age at menarche and type 2 diabetes risk: the EPIC-Interact study. Diabetes Care. 36:3526–3534. doi:10.2337/dc13-0446
   PubMed Web of Science ®Google Scholar
• Fan Y-Y, Kobori H, Nakano D, Hitomi H, Mori H, Masaki T, Sun Y-X, Zhi N, Zhang L, Huang W. 2013. Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats. Horm Metab Res. 45:338–343. doi:10.1055/s-0032-1331256
   PubMed Web of Science ®Google Scholar
• Graves LE, Donaghue KC. 2019. Management of diabetes complications in youth. Ther Adv Endocrinol Metab. 10:2042018819863226. doi:10.1177/2042018819863226
   Web of Science ®Google Scholar
• Gul Baykalir B, Ciftci O, Cetin A, Basak Turkmen N. 2018. The protective effect of fish oil against cisplatin induced eye damage in rats. Cutan Ocular Toxicol. 37:151–156. doi:10.1080/15569527.2017.1361438
   PubMed Web of Science ®Google Scholar
• Gürbüz P, Düzova H, Yildiz A, Çakan P, Kaya GB, Bağ HGG, Durhan M, Gül CC, Taşlidere AÇ. 2019. Effects of noopept on cognitive functions and pubertal period in rats with diabetes. Life Sci. 233:116698. doi:10.1016/j.lfs.2019.116698
   PubMed Web of Science ®Google Scholar
• Harjutsalo V, Maric-Bilkan C, Forsblom C, Groop P-H, Group FS. 2016. Age at menarche and the risk of diabetic microvascular complications in patients with type 1 diabetes. Diabetologia. 59:472–480. doi:10.1007/s00125-015-3816-0
   PubMed Web of Science ®Google Scholar
• Heng L, Comyn O, Peto T, Tadros C, Ng E, Sivaprasad S, Hykin P. 2013. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabetic Med. 30:640–650. doi:10.1111/dme.12089
   PubMed Web of Science ®Google Scholar
• Hsu Y-H, Chen Y-C, Chen Y-W, Chiu T-H, Kuo Y-T, Chen C-H. 2020. Far-infrared radiation prevents decline in β-cell mass and function in diabetic mice via the mitochondria-mediated sirtuin1 pathway. Metabolism. 104:154143. doi:10.1016/j.metabol.2020.154143
   PubMed Web of Science ®Google Scholar
• Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O’neal DN, Januszewski AS. 2015. Biomarkers in diabetic retinopathy. Rev Diabetic Stud. 12:159–195. doi:10.1900/RDS.2015.12.159
   PubMedGoogle Scholar
• Jigheh ZA, Haghjo AG, Argani H, Roshangar L, Rashtchizadeh N, Sanajou D, Ahmad SNS, Rashedi J, Dastmalchi S, Abbasi MM. 2019. Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis. Iran J Basic Med Sci. 22:384–390. doi:10.22038/ijbms.2019.31788.7651
   PubMed Web of Science ®Google Scholar
• Karahan F (2015). Erkek sıçanlarda poliklorlu bifenillerin (Aroklor 1254) neden olduğu reproduktif hasara karşı tetrandrinin koruyucu etkilerinin araştırılması [ Master’s thesis]. İnönü Üniversitesi Sağlık Bilimleri Enstitüsü. https://tez.yok.gov.tr/UlusalTezMerkezi/tezSorguSonucYeni.jsp.
   Google Scholar
• Katsuda Y, Sasase T, Tadaki H, Mera Y, Motohashi Y, Kemmochi Y, Toyoda K, Kakimoto K, Kume S, Ohta T. 2015. Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin. Exp Anim. 64:161–169. doi:10.1538/expanim.14-0084
   PubMed Web of Science ®Google Scholar
• Kelsey MM, Zeitler PS. 2016. Insulin resistance of puberty. Curr Diabetes Rep. 16:1–6. doi:10.1007/s11892-016-0751-5
   PubMed Web of Science ®Google Scholar
• Khadilkar A, Oza C. 2022. Glycaemic control in youth and young adults: challenges and solutions. Diabetes Metab Syndr Obes Targ Ther. 15:121–129. doi:10.2147/DMSO.S304347
   PubMed Web of Science ®Google Scholar
• Kitada M, Koya D. 2021. Autophagy in metabolic disease and ageing. Nat Rev Endocrinol. 17:647–661. doi:10.1038/s41574-021-00551-9
   PubMed Web of Science ®Google Scholar
• Koffi Kouame AIP, Akang EN, Moodley R, Naidu EC, Azu OO. 2019. Histological and biochemical effects of Cinnamomum cassia nanoparticles in kidneys of diabetic Sprague-Dawley rats. Bos J Basic Med Sci. 19:138–145. doi:10.17305/bjbms.2019.3481
   PubMed Web of Science ®Google Scholar
• Li L, Li Y-L, Zhou Y-F, Ge Z-Y, Wang L-L, Li Z-Q, Guo Y-J, Jin L, Ren Y, Liu J-X. 2017. Jiangtang Xiaozhi Recipe (降糖消脂方) prevents diabetic retinopathy in streptozotocin-induced diabetic rats. Chin J Integ Med. 23:425–432. doi:10.1007/s11655-016-2595-x
   PubMed Web of Science ®Google Scholar
• Lind M, Pivodic A, Svensson A-M, Ólafsdóttir AF, Wedel H, Ludvigsson J. 2019. HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study. Br Med J. 366:l4894. doi:10.1136/bmj.l4894
   PubMedGoogle Scholar
• Lytvyn Y, Bjornstad P, Pun N, Maahs DM, Perkins B, Cherney DZ. 2016. New and old agents in the management of diabetic nephropathy. Curr Opin Nephrol Hypertens. 25:232–239. doi:10.1097/MNH.0000000000000214
   PubMed Web of Science ®Google Scholar
• Marcovecchio M, Tossavainen P, Dunger D. 2010. Prevention and treatment of microvascular disease in childhood type 1 diabetes. Br Med Bull. 94:145–164. doi:10.1093/bmb/ldp053
   PubMed Web of Science ®Google Scholar
• Matsui T, Nakashima S, Nishino Y, Ojima A, Nakamura N, Arima K, Fukami K, Okuda S, Yamagishi S-I. 2015. Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis. Lab Invest. 95:525–533. doi:10.1038/labinvest.2015.35
   PubMed Web of Science ®Google Scholar
• Mellado-Gil JM, Cobo-Vuilleumier N, Gauthier BR. 2012. Islet β-cell mass preservation and regeneration in diabetes mellitus: four factors with potential therapeutic interest. (Corrigendum to “Islet β-cell mass preservation and regeneration in diabetes mellitus: four factors with potential therapeutic interest.” J Transpl. 2019). J transpl. 2012. Article ID 230870. doi:10.1155/2019/3281921
   Google Scholar
• Öberg D, Salemyr J, Örtqvist E, Juul A, Bang P. 2018. A longitudinal study of serum insulin‐like growth factor‐i levels over 6 years in a large cohort of children and adolescents with type 1 diabetes mellitus: a marker reflecting diabetic retinopathy. Ped Diabetes. 19:972–978. doi:10.1111/pedi.12681
   PubMed Web of Science ®Google Scholar
• Oguntibeju OO. 2019. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 11:45–63.
   PubMedGoogle Scholar
• Ostrovskaya R, Gudasheva T, Voronina T, Seredenin S. 2002. The original novel nootropic and neuroprotective agent Noopept. Eks Klin Farmakol. 65:66–72.
   Google Scholar
• Ostrovskaya R, Ozerova I, Gudascheva T, Kapitsa I, Ivanova E, Voronina T, Seredenin S. 2013. Efficiency of noopept in streptozotocin-induced diabetes in rats. Bull Exp Biol Med. 154:334–338. doi:10.1007/s10517-013-1944-4
   PubMed Web of Science ®Google Scholar
• Ostrovskaya R, Ozerova I, Gudascheva T, Kapitsa I, Ivanova E, Voronina T, Seredenin S. 2014a. Comparative activity of proline-containing dipeptide noopept and inhibitor of dipeptidyl peptidase-4 sitagliptin in a rat model of developing diabetes. Bull Exp Biol Med. 156:342–346. doi:10.1007/s10517-014-2345-z
   PubMed Web of Science ®Google Scholar
• Ostrovskaya R, Vakhitova YV, Kuzmina US, Salimgareeva MK, Zainullina LF, Gudasheva TA, Vakhitov VA, Seredenin SB. 2014b. Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation. J Biomed Sci. 21:1–9. doi:10.1186/s12929-014-0074-2
   Google Scholar
• Ostrovskaya R, Zolotov N, Ozerova I, Ivanova E, Kapitsa I, Taraban K, Michunskaya A, Voronina T, Gudasheva T, Seredenin S. 2014c. Noopept normalizes parameters of the incretin system in rats with experimental diabetes. Bull Exp Biol Med. 157:344–349. doi:10.1007/s10517-014-2562-5
   PubMed Web of Science ®Google Scholar
• Pulgaron ER, Delamater AM. 2014. Obesity and type 2 diabetes in children: epidemiology and treatment. Curr Diabetes Rep. 14:508–520. doi:10.1007/s11892-014-0508-y
   PubMed Web of Science ®Google Scholar
• Roglic G. 2016. WHO Global report on diabetes: a summary. Int J Noncommun Dis. 1:3–8. doi:10.4103/2468-8827.184853
   Google Scholar
• Sifuentes-Franco S, Pacheco-Moisés FP, Rodríguez-Carrizalez AD, Miranda-Díaz AG. 2017. The role of oxidative stress, mitochondrial function, and autophagy in diabetic polyneuropathy. J Diabetes Res. 2017:1–15. Article 1673081. doi:10.1155/2017/1673081
   Web of Science ®Google Scholar
• Silvares RR, Pereira ENGS, Flores EEI, Estato V, Reis PA, Silva I, Machado MP, Neto HCdCF, Tibiriça E, Daliry A. 2016. Combined therapy with metformin and insulin attenuates systemic and hepatic alterations in a model of high‐fat diet‐streptozotocin‐induced diabetes. Int J Exp Pathol. 97:266–277. doi:10.1111/iep.12184
   PubMed Web of Science ®Google Scholar
• Sumi A, Iwase M, Nakamura U, Fujii H, Ohkuma T, Ide H, Jodai‐kitamura T, Komorita Y, Yoshinari M, Kitazono T. 2018. Impact of age at menarche on obesity and glycemic control in Japanese patients with type 2 diabetes: fukuoka Diabetes Registry. J Diabetes Invest. 9:1216–1223. doi:10.1111/jdi.12839
   PubMed Web of Science ®Google Scholar
• Sun J, Devish K, Langer WJ, Carmines PK, Lane PH. 2007. Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats. Am J Physiol Ren Physiol. 292:F1681–1690. doi:10.1152/ajprenal.00482.2006
   PubMed Web of Science ®Google Scholar
• Ulas M, Orhan C, Tuzcu M, Ozercan IH, Sahin N, Gencoglu H, Komorowski JR, Sahin K. 2015. Anti-diabetic potential of chromium histidinate in diabetic retinopathy rats. BMC Compl Alt Med. 15:1–8. doi:10.1186/s12906-015-0537-3
   PubMed Web of Science ®Google Scholar
• Vardi N, Parlakpinar H, Ates B, Cetin A, Otlu A. 2013. The protective effects of Prunus armeniaca L (apricot) against methotrexate-induced oxidative damage and apoptosis in rat kidney. J Physiol Biochem. 69:371–381. doi:10.1007/s13105-012-0219-2
   PubMed Web of Science ®Google Scholar
• Vardi N, Parlakpinar H, Ozturk F, Ates B, Gul M, Cetin A, Erdogan A, Otlu A. 2008. Potent protective effect of apricot and β-carotene on methotrexate-induced intestinal oxidative damage in rats. Food Chem Toxicol. 46:3015–3022. doi:10.1016/j.fct.2008.05.039
   PubMed Web of Science ®Google Scholar
• Wajchenberg BL. 2007. β-cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 28:187–218. doi:10.1210/10.1210/er.2006-0038
   PubMed Web of Science ®Google Scholar
• Yin J, Huang J, Chen C, Gao N, Wang F, Fu-Shin XY. 2011. Corneal complications in streptozocin-induced type I diabetic rats. Invest Ophthal Vis Sci. 52:6589–6596. doi:10.1167/iovs.11-7709
   PubMed Web of Science ®Google Scholar